Company Overview and News

 
REDT ENERGY PLC 2018 Q2 - Results - Earnings Call Slides

2018-09-14 seekingalpha
The following slide deck was published by REDT ENERGY PLC in conjunction with their 2018 Q2 earnings call.
RED

 
REDT ENERGY PLC 2017 Q4 - Results - Earnings Call Slides

2018-05-18 seekingalpha
The following slide deck was published by REDT ENERGY PLC in conjunction with their 2017 Q4 earnings call.
RED

116
Companies To Benefit From The Stationary Energy Storage Boom

2018-04-30 seekingalpha - 1
Types of stationary energy storage. Hydro has historically dominated, however Li-ion battery storage is growing fast. Vanadium flow can also have a place.
RPC SRHYY OGFGY NMT EFR RDRUY AES JCI SBR LGO SCEDN GE RPCGY SCEDP CAMCF SHCAY BSWQY ENPH RNO DDAIF RED RPCGF TNG GRRLF AVL SIEGY KRC ENIC STNUF TON ENIA RES GED SYR GM UUUU ATVVF RFX PCRFY GEC LGORF NIPNF SYAAF SCE RRSSF GRR TSLA ESNC GNE ENS SNE OGFGF ORG

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to LSE:RED / REDT ENERGY PLC on message board site Silicon Investor.

NFL Prediction Contest NFL Prediction Contest NFL Prediction Contest Survivalists, Disaster Preparedness and Living Off the Grid Survivalists, Disaster Preparedness and Living Off the Grid Survivalists, Disaster Preparedness and Living Off the Grid
Africa and its Issues- Why Have We Ignored Africa? Africa and its Issues- Why Have We Ignored Africa? Africa and its Issues- Why Have We Ignored Africa? Predictive Markets Predictive Markets Predictive Markets
Microcap Potential Homeruns--Credible, and Reporting Microcap Potential Homeruns--Credible, and Reporting Microcap Potential Homeruns--Credible, and Reporting Thoroughbred Horse Racing Thoroughbred Horse Racing Thoroughbred Horse Racing
RedHat Linux distributor -- IPO RedHat Linux distributor -- IPO RedHat Linux distributor -- IPO Whodunit? Two Stockbrokers Murdered in Jersey; No Clues Whodunit? Two Stockbrokers Murdered in Jersey; No Clues Whodunit? Two Stockbrokers Murdered in Jersey; No Clues
FM Resources Corp FMR.V (was Redell Mining) FM Resources Corp FMR.V (was Redell Mining) FM Resources Corp FMR.V (was Redell Mining) The Epic American Credit and Bond Bubble Laboratory The Epic American Credit and Bond Bubble Laboratory The Epic American Credit and Bond Bubble Laboratory